QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS5-Region Domestic Shipping
What is BPC-157 + TB-500 Blend?
BPC-157 + TB-500 Blend (Dual-mechanism recovery stack (non-overlapping targets)) is a Pre-blended equimolar BPC-157 + TB-500 per vial. Pre-blended combination at defined ratios of BPC-157 (NO synthase/VEGF/tenocyte activation) and TB-500 (actin sequestration/NF-κB anti-inflammatory/independent angiogenesis). Mechanistic rationale: non-overlapping molecular targets produce complementary tissue repair effects via two distinct biological pathways.
Research Applications
Non-Overlapping Dual Mechanisms
BPC-157 NOS+VEGF pathway + TB-500 actin+NF-κB pathway combined
Controlled-Ratio Combination
Defined ratio protocols without separate compounding
Synergy Research
Blend vs individual component parallel arms — additive vs synergistic
Multi-Tissue Repair
Tendon, GI, nerve, cardiac — all tissue types in one protocol
Convenience Research
Single reconstitution for dual-mechanism repair studies
Quick Specs
| Form | Pre-blended equimolar BPC-157 + TB-500 per vial |
| Purity | ≥99% by HPLC — every batch |
| CAS Number | Not applicable (dual peptide combination) |
| Molecular Formula | Sequence-specific (BPC-157 + TB-500 fragment) |
| Peptide Type | Dual Regenerative Peptide Blend |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house Fmoc SPPS — Qingdao, China |
| Storage | -20°C sealed | 2–8°C reconstituted (2–4 weeks) |
| Shelf Life | 24 months unopened |
